Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply

Dave E.W. Van Der Kruijssen; Sjoerd G. Elias; Johannes H.W. De Wilt

doi:10.1001/jamasurg.2021.7585

Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply

Dave E.W. Van Der Kruijssen
, Sjoerd G. Elias
, Johannes H.W. De Wilt^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	551-552
Number of pages	2
Journal	JAMA Surgery
Volume	157
Issue number	6
DOIs	https://doi.org/10.1001/jamasurg.2021.7585
Publication status	Published - Jun 2022

Access to Document

10.1001/jamasurg.2021.7585

jamasurgery_van_der_kruijssen_2022_lr_210046_1653666752.85118Final published version, 64.6 KBLicence: Taverne

Cite this

@article{14c1603f6d6743c0b948dd294b59e609,

title = "Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply",

author = "\{Van Der Kruijssen\}, \{Dave E.W.\} and Elias, \{Sjoerd G.\} and \{De Wilt\}, \{Johannes H.W.\}",

note = "Funding Information: Conflict of Interest Disclosures: Dr van der Kruijssen reported a grant from Dutch Cancer Society and an unrestricted grant from Hoffmann-La Roche Ltd during the conduct of the study. Dr de Wilt reported a grant from Dutch Cancer Society and an unrestricted grant from Hoffmann-La Roche Ltd during the conduct of the study and grants from Dutch Cancer Society, Bergh in het Zadel Foundation, ZonMw, and Medtronic outside the submitted work. No other disclosures were reported.",

year = "2022",

month = jun,

doi = "10.1001/jamasurg.2021.7585",

language = "English",

volume = "157",

pages = "551--552",

journal = "JAMA Surgery",

issn = "2168-6254",

publisher = "American Medical Association",

number = "6",

}

TY - JOUR

T1 - Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply

AU - Van Der Kruijssen, Dave E.W.

AU - Elias, Sjoerd G.

AU - De Wilt, Johannes H.W.

N1 - Funding Information: Conflict of Interest Disclosures: Dr van der Kruijssen reported a grant from Dutch Cancer Society and an unrestricted grant from Hoffmann-La Roche Ltd during the conduct of the study. Dr de Wilt reported a grant from Dutch Cancer Society and an unrestricted grant from Hoffmann-La Roche Ltd during the conduct of the study and grants from Dutch Cancer Society, Bergh in het Zadel Foundation, ZonMw, and Medtronic outside the submitted work. No other disclosures were reported.

PY - 2022/6

Y1 - 2022/6

UR - https://www.scopus.com/pages/publications/85124947815

U2 - 10.1001/jamasurg.2021.7585

DO - 10.1001/jamasurg.2021.7585

M3 - Comment/Letter to the editor

C2 - 35171236

AN - SCOPUS:85124947815

SN - 2168-6254

VL - 157

SP - 551

EP - 552

JO - JAMA Surgery

JF - JAMA Surgery

IS - 6

ER -

Comments on the CAIRO4 Trial Secondary Outcomes Report-Reply

Access to Document

Other files and links

Cite this